Application

19392967 · Methods for Treating Atopic Dermatitis by Administering an IL-4R Antagonist

Filed 2025-11-18 · Granted The official file ↗ · Art unit 1674 · Examiner Prema Maria Mertz Easy · CPC A61K 31/573 · Sanofi Biotechnology · Schwabe W&W, PC / Regeneron Pharmaceuticals, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

4.7 mo

to disposition 8.4 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.